DEDD2 activators belong to a class of chemicals that are specifically tailored to modulate the activity of the enzyme DEDD2, a protein that is involved in a variety of cellular processes. The acronym DEDD2 stands for "Death Effector Domain-containing protein 2," which is indicative of the type of domain that is present within this protein and suggests its involvement in cellular mechanisms. Activators of DEDD2 aim to enhance the protein's natural function by increasing its activity within the cell. The mechanisms by which these activators exert their effects can vary; they may interact directly with the DEDD2 protein, facilitating its engagement with other proteins or substrates, or they may influence the protein's function indirectly through the modulation of related signaling pathways. The development of DEDD2 activators requires a comprehensive understanding of the protein's structure and the molecular pathways it influences, necessitating the use of sophisticated biochemistry and molecular biology techniques to elucidate these complex interactions.
The chemical synthesis and identification of DEDD2 activators involve rigorous experimentation and optimization. Scientists utilize combinatorial chemistry approaches to generate diverse libraries of potential activator compounds. These libraries are then subjected to high-throughput screening assays to identify molecules that display activity-enhancing effects on DEDD2. The hit compounds from these screens are further studied to determine their mechanism of action, often employing methods such as affinity chromatography, which helps isolate and identify direct interactions between the activator and the DEDD2 protein, as well as other related proteins within the same pathway. Once promising activator candidates are identified, they undergo cycles of chemical modification to improve their potency, selectivity, and cellular uptake.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Topoisomerase II inhibitor that can induce DNA damage, leading to activation of the DNA damage response (DDR) pathways. This stress may, in turn, upregulate DEDD2 as part of the cellular response to maintain genomic integrity. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Topoisomerase I inhibitor that causes DNA strand breaks, potentially activating DDR pathways that could result in increased expression of DEDD2 due to its role in apoptotic signaling and DNA repair processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
DNA crosslinking agent that induces DNA damage, possibly triggering DDR pathways and thereby enhancing the expression of DEDD2, which is thought to participate in the cellular response to DNA damage. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
MDM2 antagonist that stabilizes p53, potentially increasing the transcription of DEDD2 due to the role of p53 in the regulation of apoptosis-related genes. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor that can cause the accumulation of ubiquitinated proteins, leading to cellular stress and potentially increasing the expression of DEDD2 as part of the unfolded protein response. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Anthracycline antibiotic that intercalates DNA and inhibits topoisomerase II, leading to DNA damage and the possible activation of DDR pathways, which could enhance the expression of DEDD2. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Antimetabolite that incorporates into RNA and DNA, causing damage and potentially activating DDR pathways, which could lead to the upregulation of DEDD2 as the cell responds to the stress. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Transcription inhibitor that intercalates into DNA, causing stress that may enhance the expression of DEDD2 through the activation of stress response pathways. | ||||||